REQUEST A DEMO
Total
USD $0.00
FAQ
Secure shopping

Pharma & Healthcare

The Pharma & Healthcare industry is of vital importance for human and economic development, providing a wide range of goods and services relevant to the promotion of health at all stages in the healthcare process – from prevention and treatment to rehabilitation and palliative care. It is one of the fastest-growing industries, supported by profound demographic changes, the rising incidence of non-communicable diseases, and surging per capita health spending in both developed and emerging markets. The industry is also one of the major innovators, with increasing expenditures on development of new molecules, biotechnology and adoption of new technologies that provide advanced healthcare and ensure the longevity of the population.

The Pharma & Healthcare industry comprises the manufacture of pharmaceuticals for human and veterinary use, medical equipment and related supplies. It also includes providers of ambulatory health services, medical and diagnostic laboratories, hospitals, and nursing and residential care facilities.

1 2
Hungary Pharma and Healthcare Sector Report 2019/2020 - Page 1
Hungary Pharma and Healthcare Sector Report 2019/2020 EMIS Insights Industry Reports

The changing demographic and disease profiles of Hungary were the drivers of the expansion of health expenditure in recent years. As a result, the country spent 7.4% of its GDP on healthcare in 2016, still below the EU average. The government ...

View more details
USD 495 Date: August 2019 Language: English
Format: PDF
Add to basket
Turkey Pharma and Healthcare Sector Report 2019/2020 - Page 1
Turkey Pharma and Healthcare Sector Report 2019/2020 EMIS Insights Industry Reports

Turkey’s healthcare system has been fully reformed under the 2003-2013 Health Transformation Programme (HTP), which helped expand the coverage and quality of health services across the country. Health insurance coverage reached 98.4% of the ...

View more details
USD 495 Date: June 2019 Language: English
Format: PDF
Add to basket
Russia Pharma and Healthcare Sector Report 2019/2020 - Page 1
Russia Pharma and Healthcare Sector Report 2019/2020 EMIS Insights Industry Reports

The economy’s return to growth provided a strong impetus to the Russian healthcare sector in 2017. Healthcare expenditure grew by a robust 22% y/y, when measured in US dollar terms, the first increase in many years. However, at USD 92bn in 2017 ...

View more details
USD 495 Date: June 2019 Language: English
Format: PDF
Add to basket
Czech Republic Pharma and Healthcare Sector Report 2019/2020 - Page 1
Czech Republic Pharma and Healthcare Sector Report 2019/2020 EMIS Insights Industry Reports

The gross value added (GVA) of the Czech pharmaceutical sector amounted to CZK 19.4bn in 2017, increasing by a real 11.1% y/y. The sector accounted for 0.4% of the GDP that year. The pharmaceutical sector employed 9,855 workers in 2017, accounting ...

View more details
USD 495 Date: March 2019 Language: English
Format: PDF
Add to basket
Turkey Pharma and Healthcare Sector Report 2018/2019 - Page 1
Turkey Pharma and Healthcare Sector Report 2018/2019 EMIS Insights Industry Reports

Turkey’s health insurance coverage reaches 98.4% of the population, according to the OECD Health Statistics 2017. The state, through the Ministry of Health (MoH), is the main provider of health services in the country, which still has very low ...

View more details
USD 495 Date: July 2018 Language: English
Format: PDF
Add to basket
Romania Pharma and Healthcare Sector Report 2018/2019 - Page 1
Romania Pharma and Healthcare Sector Report 2018/2019 EMIS Insights Industry Reports

Expenditure on healthcare in Romania reached RON 35.2bn in 2015, according to data provided by Eurostat. Total expenditure on healthcare was equal to 4.94% of GDP in that year. The Romanian healthcare sector was characterised by the lowest per capita ...

View more details
USD 495 Date: July 2018 Language: English
Format: PDF
Add to basket
Hungary Pharma and Healthcare Sector Report 2018/2019 - Page 1
Hungary Pharma and Healthcare Sector Report 2018/2019 EMIS Insights Industry Reports

Total expenditure on healthcare in Hungary in 2015 reached HUF 2,460bn, up by 6.3% y/y. Government and compulsory health care financing schemes made up 67% of the expenditure, followed by private out-of-pocket spending (29%). Voluntary healthcare ...

View more details
USD 495 Date: June 2018 Language: English
Format: PDF
Add to basket
Poland Healthcare Sector Report 2017/2021 - Page 1
Poland Healthcare Sector Report 2017/2021 EMIS Insights Industry Reports

In 2016 Poland’s healthcare expenditure grew by 4.5% y/y to PLN 119.27bn, representing 6.4% of the GDP. Public healthcare spending in Poland is one of the lowest compared to the EU average, which hovers around 6.5 % of GDP. The bulk of the ...

View more details
USD 995 Date: April 2018 Language: English
Format: PDF
Add to basket
Russia Pharma and Healthcare Report 2018/2019 - Page 1
Russia Pharma and Healthcare Report 2018/2019 EMIS Insights Industry Reports

Russia’s healthcare and pharmaceutical sector was badly affected by the 2015-2016 recession, which resulted in a sharp drop in government spending, while the weak rouble and high inflation cut into households’ disposable incomes. Though ...

View more details
USD 495 Date: February 2018 Language: English
Format: PDF
Add to basket
Czech Republic Pharma and Healthcare Sector Report 2018/2019 - Page 1
Czech Republic Pharma and Healthcare Sector Report 2018/2019 EMIS Insights Industry Reports

The pharmaceutical sector in the Czech Republic generated a gross value added (GVA) of CZK 18.9bn in 2016, up by 8.2% y/y in real terms. It accounted for 0.44% of the total GVA in the economy in 2016. The sector employed 9,438 workers. Total ...

View more details
USD 495 Date: January 2018 Language: English
Format: PDF
Add to basket
1 2